{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:47:01Z","timestamp":1792806421021,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,10,8]],"date-time":"2016-10-08T00:00:00Z","timestamp":1475884800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Gastro"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s11938-016-0113-z","type":"journal-article","created":{"date-parts":[[2016,10,8]],"date-time":"2016-10-08T06:47:55Z","timestamp":1475909275000},"page":"410-419","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Chronic Unexplained Nausea and Vomiting or Gastric Neuromuscular Dysfunction (GND)? An Update on Nomenclature, Pathophysiology and Treatment, and Relationship to Gastroparesis"],"prefix":"10.1007","volume":"14","author":[{"given":"Kimberly N.","family":"Harer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj J.","family":"Pasricha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,8]]},"reference":[{"key":"113_CR1","doi-asserted-by":"crossref","unstructured":"Stanghellini V, Chan FKL, Hasler WL, Malagelada JR, Suzuki H, Tack J, et al. Gastroduodenal disorders. Gastroenterology. 150:1380\u201392. This article outlines the Rome IV criteria for Functional Gastrointestinal Disorders, focusing on gastroduodenal disorders such as functional dyspepsia and Chronic Nausea and Vomiting Syndrome.","DOI":"10.1053\/j.gastro.2016.02.011"},{"key":"113_CR2","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.cgh.2011.03.003","volume":"9","author":"PJ Pasricha","year":"2011","unstructured":"Pasricha PJ, Colvin R, Yates K, et al. Characteristics of patients with chronic unexplained nausea and vomiting and normal gastric emptying. Clin Gastroenterol Hepatol. 2011;9:567\u201376. Multi-center study published by the Gastroparesis Consortium that compared patients with gastroparesis symptoms and either delayed emptying (gastroparesis) or normal gastric emptying (CUNV). Investigators found the two groups to be clinically indistinguishable.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"113_CR3","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s10620-009-0717-4","volume":"54","author":"R Anaparthy","year":"2009","unstructured":"Anaparthy R, Pehlivanov N, Grady J, et al. Gastroparesis and gastroparesis-like syndrome: response to therapy and its predictors. Dig Dis Sci. 2009;54:1003\u201310.","journal-title":"Dig Dis Sci"},{"key":"113_CR4","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s11938-005-0023-y","volume":"8","author":"KW Olden","year":"2005","unstructured":"Olden KW, Crowell MD. Chronic nausea and vomiting: new insights and approach to treatment. Curr Treat Options Gastroenterol. 2005;8:305\u201310.","journal-title":"Curr Treat Options Gastroenterol"},{"key":"113_CR5","first-page":"1377","volume-title":"Rome III: the functional gastrointestinal disorders","author":"DA Drossman","year":"2006","unstructured":"Drossman DA, Corazziari E, Delvaux M, et al. Rome III: the functional gastrointestinal disorders. 130 ed; 2006. p. 1377\u2013556.","edition":"130"},{"key":"113_CR6","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/nmo.12709","volume":"28","author":"JK Dibaise","year":"2016","unstructured":"Dibaise JK, Islam RS, Dueck AC, et al. Psychological distress in Rome III functional dyspepsia patients presenting for testing of gastric emptying. Neuroenterol Motil. 2016;28:196\u2013205.","journal-title":"Neuroenterol Motil"},{"key":"113_CR7","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1111\/j.1572-0241.2001.03683.x","volume":"96","author":"NJ Talley","year":"2001","unstructured":"Talley NJ, Verlinden M, Jones M. Can symptoms discriminate among those with delayed or normal gastric emptying in dysmotility-like dyspepsia? Am J Gastroenterol. 2001;96:1422\u20138.","journal-title":"Am J Gastroenterol"},{"key":"113_CR8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/gut.2005.089508","volume":"56","author":"G Karamanolis","year":"2007","unstructured":"Karamanolis G, Caenepeel P, Arts J, et al. Determinants of symptom pattern in idiopathic severely delayed gastric emptying: gastric emptying rate or proximal stomach dysfunction? Gut. 2007;56:29\u201336.","journal-title":"Gut"},{"key":"113_CR9","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.2337\/diacare.26.11.3116","volume":"26","author":"M Samsom","year":"2003","unstructured":"Samsom M, Vermeijden JR, Smout AJ, et al. Prevalence of delayed gastric emptying in diabetic patients and relationship to dyspeptic symptoms: a prospective study in unselected diabetic patients. Diabetes Care. 2003;26:3116\u201322.","journal-title":"Diabetes Care"},{"issue":"7","key":"113_CR10","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1053\/j.gastro.2011.02.078","volume":"140","author":"P Janssen","year":"2011","unstructured":"Janssen P, Van Oudenhove L, Bisschops R, Tack J. Idiopathic gastroparesis or functional dyspepsia with delayed gastric emptying: where is the difference? Gastroenterology. 2011;140(7):2145\u20136.","journal-title":"Gastroenterology"},{"issue":"12","key":"113_CR11","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1136\/gutjnl-2013-306084","volume":"63","author":"V Stanghellini","year":"2014","unstructured":"Stanghellini V, Tack J. Gastroparesis: separate entity or just a part of dyspepsia? Gut. 2014;63(12):1972\u20138. This article discusses the clinical overlap between gastroparesis and dyspepsia and discusses how the two disorders may be part of a disease spectrum.","journal-title":"Gut"},{"issue":"5","key":"113_CR12","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1053\/j.gastro.2011.01.046","volume":"140","author":"M Grover","year":"2011","unstructured":"Grover M, Farrugia G, Lurken MS, et al. Cellular changes in diabetic and idiopathic gastroparesis. Gastroenterology. 2011;140(5):1575\u201385. Prospective case-control trial with full-thickness gastric biopsy specimens demonstrating cellular abnormalities in gastroparesis patients, including loss of Kit expression that suggests a loss of Interstitial Cells of Cajal","journal-title":"Gastroenterology"},{"key":"113_CR13","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/j.1582-4934.2011.01451.x","volume":"16","author":"MS Faussone-Pellegrini","year":"2012","unstructured":"Faussone-Pellegrini MS, Grover M, Pasricha PJ, et al. Ultrastructural differences between diabetic and idiopathic gastroparesis. J Cell Mol Med. 2012;16:1573\u201381.","journal-title":"J Cell Mol Med"},{"key":"113_CR14","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1053\/j.gastro.2012.05.036","volume":"143","author":"G O\u2019Grady","year":"2012","unstructured":"O\u2019Grady G, Angeli TR, Du P, et al. Abnormal initiation and conduction of slow-wave activity in gastroparesis, defined by high-resolution electrical mapping. Gastroenterology. 2012;143:589\u2013598.e1\u2013e3.","journal-title":"Gastroenterology"},{"issue":"1","key":"113_CR15","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1053\/j.gastro.2015.04.003","volume":"149","author":"TR Angeli","year":"2015","unstructured":"Angeli TR, Cheng LK, Du P, Wang TH, Bernard CE, Vannucchi MG, et al. Loss of interstitial cells of Cajal and patterns of gastric dysrhythmia in patients with chronic unexplained nausea and vomiting. Gastroenterology. 2015;149(1):56\u201366.e5. A case-control study of CUNV patients and age-matched controls that demonstrated a significantly lower ICC density along with dysrhythmic slow wave activity in CUNV patients.","journal-title":"Gastroenterology"},{"issue":"Issue 4, Supple","key":"113_CR16","doi-asserted-by":"crossref","first-page":"S215","DOI":"10.1016\/S0016-5085(16)30797-1","volume":"150","author":"PJ Pasricha","year":"2016","unstructured":"Pasricha PJ, Grover M, Yates K, et al. Gastroparesis and functional dyspepsia of postprandial discomfort phenotype have similar clinical, pathophysiological and histopathological features. Gastroenterology. 2016;150(Issue 4, Supplement 1):S215.","journal-title":"Gastroenterology"},{"issue":"2","key":"113_CR17","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1056\/NEJMoa1515725","volume":"375","author":"RM Navari","year":"2016","unstructured":"Navari RM, Qin R, Ruddy KJ, Liu H, Powell SF, Bajaj M, Dietrich L, et al. Olanzapine for the prevention of chemotherapy-induced nausea and vomiting. N Engl J Med. 2016;375(2):134\u201342.","journal-title":"N Engl J Med"},{"issue":"2","key":"113_CR18","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3109\/15360288.2015.1035831","volume":"29","author":"M Langley-DeGroot","year":"2015","unstructured":"Langley-DeGroot M, Ma JD, Hirst J, Roeland EJ. Olanzapine in the treatment of refractory nausea and vomiting: a case report and review of the literature. J Pain Palliat Care Pharmacother. 2015;29(2):148\u201352.","journal-title":"J Pain Palliat Care Pharmacother"},{"issue":"2","key":"113_CR19","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.critrevonc.2015.02.010","volume":"95","author":"C Fonte","year":"2015","unstructured":"Fonte C, Fatigoni S, Roila F. A review of olanzapine as an antiemetic in chemotherapy-induced nausea and vomiting and in palliative care patients. Crit Rev Oncol Hematol. 2015;95(2):214\u201321.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"9","key":"113_CR20","doi-asserted-by":"crossref","first-page":"G796","DOI":"10.1152\/ajpgi.00130.2013","volume":"306","author":"J Yin","year":"2014","unstructured":"Yin J, Song J, Lei Y, Xu X, Chen JD. Prokinetic effects of mirtazapine on gastrointestinal transit. Am J Physiol Gastrointest Liver Physiol. 2014;306(9):G796\u2013801.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"3","key":"113_CR21","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.cgh.2015.09.043","volume":"14","author":"J Tack","year":"2016","unstructured":"Tack J, Ly HG, Carbone F, Vanheel H, Vanuytsel T, Holvoet L, et al. Efficacy of mirtazapine in patients with functional dyspepsia and weight loss. Clin Gastroenterol Hepatol. 2016;14(3):385\u2013392.e4. A randomized, placebo-controlled pilot study that evaluated mirtazapine versus placebo in functional dyspepsia patients and found a reduction in dyspepsia symptom severity and early satiety in the mirtazapine group compared to baseline measurements.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"22","key":"113_CR22","doi-asserted-by":"crossref","first-page":"5260","DOI":"10.3748\/wjg.v22.i22.5260","volume":"22","author":"SM Jiang","year":"2016","unstructured":"Jiang SM, Jia L, Liu J, Shi MM, Xu MZ. Beneficial effects of antidepressant mirtazapine in functional dyspepsia patients with weight loss. World J Gastroenterol. 2016;22(22):5260\u20136. A randomized, placebo-controlled trial comparing mirtazapine, paroxetine, and placebo therapy. Mirtazapine worked best with improvement in functional dyspepsia symptoms, depressive symptoms, and weight gain.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"113_CR23","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1053\/j.gastro.2015.04.020","volume":"149","author":"NJ Talley","year":"2015","unstructured":"Talley NJ, Locke GR, Saito YA, Almazar AE, Bouras EP, Howden CW, et al. Effect of amitriptyline and escitalopram on functional dyspepsia: a multicenter, randomized controlled study. Gastroenterology. 2015;149(2):340\u20139.e2.","journal-title":"Gastroenterology"},{"issue":"4","key":"113_CR24","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/nmo.12296","volume":"26","author":"HP Parkman","year":"2014","unstructured":"Parkman HP, Carlson MR, Gonyer D. Metoclopramide nasal spray is effective in symptoms of gastroparesis in diabetics compared to conventional oral tablet. Neurogastroenterol otil. 2014;26(4):521\u20138.","journal-title":"Neurogastroenterol otil"},{"issue":"7","key":"113_CR25","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.cgh.2014.12.030","volume":"13","author":"HP Parkman","year":"2015","unstructured":"Parkman HP, Carlson MR, Gonyer D. Metoclopramide nasal spray reduces symptoms of gastroparesis in women, but not men, with diabetes: results of a phase 2B randomized study. Clin Gastroenterol Hepatol. 2015;13(7):1256\u20131263.e1.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"113_CR26","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/nmo.12736","volume":"28","author":"J Tack","year":"2016","unstructured":"Tack J, Rotondo A, Meulemans A, Thielemans L, Cools M. Randomized clinical trial: a controlled pilot trial of the 5-HT4 receptor agonist revexepride in patients with symptoms suggestive of gastroparesis. Neurogastroenterol Motil. 2016;28(4):487\u201397.","journal-title":"Neurogastroenterol Motil"},{"issue":"Issue 4, Supple","key":"113_CR27","doi-asserted-by":"crossref","first-page":"S213","DOI":"10.1016\/S0016-5085(16)30792-2","volume":"150","author":"F Carbone","year":"2016","unstructured":"Carbone F, Rotondo A, Andrews CN, et al. A controlled cross-over trial shows benefit of prucalopride for symptom control and gastric emptying enhancement in idiopathic gastroparesis. Gastroenterology. 2016;150(Issue 4, Supplement 1):S213\u20134.","journal-title":"Gastroenterology"},{"issue":"22","key":"113_CR28","doi-asserted-by":"crossref","first-page":"6842","DOI":"10.3748\/wjg.v21.i22.6842","volume":"21","author":"TR McCarty","year":"2015","unstructured":"McCarty TR, Rustagi T. Endoscopic treatment of gastroparesis. World J Gastroenterol. 2015;21(22):6842\u20139.","journal-title":"World J Gastroenterol"},{"key":"113_CR29","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.gtc.2014.11.010","volume":"44","author":"JO Clarke","year":"2015","unstructured":"Clarke JO, Snape WJ. Pyloric sphincter therapy botulinum toxin, stents, and pyloromyotomy. Gastroenterol Clin N Am. 2015;44:127\u201336.","journal-title":"Gastroenterol Clin N Am"},{"issue":"2","key":"113_CR30","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1572-0241.2007.01676.x","volume":"103","author":"FK Friedenberg","year":"2008","unstructured":"Friedenberg FK, Palit A, Parkman HP, Hanlon A, Nelson DB. Botulinum toxin A for the treatment of delayed gastric emptying. Am J Gastroenterol. 2008;103(2):416\u201323.","journal-title":"Am J Gastroenterol"},{"key":"113_CR31","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1111\/j.1365-2036.2007.03467.x","volume":"26","author":"J Arts","year":"2007","unstructured":"Arts J, Holvoet L, Caenepeel P, et al. Clinical trial: a randomized-controlled crossover study of intrapyloric injection of botulinum toxin in gastroparesis. Aliment Pharmacol Ther. 2007;26:1251\u20138.","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl 2","key":"113_CR32","first-page":"E189","volume":"45","author":"JO Clarke","year":"2013","unstructured":"Clarke JO, RZ S, Kord Valeshabad A, et al. Through-the- scope transpyloric stent placement improves symptoms and gastric emptying in patients with gastroparesis. Endoscopy. 2013;45(Suppl 2):E189\u201390.","journal-title":"Endoscopy"},{"issue":"6","key":"113_CR33","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.gie.2015.06.051","volume":"82","author":"MA Khashab","year":"2015","unstructured":"Khashab MA, Besharati S, Ngamruengphong S, Kumbhari V, El Zein M, Stein EM, et al. Refractory gastroparesis can be successfully managed with endoscopic transpyloric stent placement and fixation (with video. Gastrointest Endosc. 2015;82(6):1106\u20139.","journal-title":"Gastrointest Endosc"},{"issue":"8","key":"113_CR34","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1111\/nmo.12854","volume":"28","author":"P Mekaroonkamol","year":"2016","unstructured":"Mekaroonkamol P, Li LY, Dacha S, Xu Y, Keilin SD, Willingham FF, et al. Gastric peroral endoscopic pyloromyotomy (G-POEM) as a salvage therapy for refractory gastroparesis: a case series of different subtypes. Neurogastroenterol Motil. 2016;28(8):1272\u20137.","journal-title":"Neurogastroenterol Motil"},{"key":"113_CR35","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.gie.2013.07.019","volume":"78","author":"MA Khashab","year":"2013","unstructured":"Khashab MA, Stein E, Clarke JO, et al. Gastric peroral endoscopic myotomy for refractory gastroparesis: first human endoscopic pyloromyotomy (with video. Gastrointest Endosc. 2013;78:764\u20138.","journal-title":"Gastrointest Endosc"},{"issue":"Suppl 1","key":"113_CR36","first-page":"E135","volume":"47","author":"JM Gonzalez","year":"2015","unstructured":"Gonzalez JM, Vanbiervliet G, Vitton V, et al. First European human gastric peroral endoscopic myotomy, for treatment of refractory gastroparesis. Endoscopy. 2015;47(Suppl 1):E135\u20136.","journal-title":"Endoscopy"},{"key":"113_CR37","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.gie.2014.03.045","volume":"80","author":"DM Chaves","year":"2014","unstructured":"Chaves DM, de Moura EG, Mestieri LH, et al. Endoscopic pyloromyotomy via a gastric submucosal tunnel dissection for the treatment of gastroparesis after surgical vagal lesion. Gas-trointest Endosc. 2014;80:164.","journal-title":"Gas-trointest Endosc"},{"key":"113_CR38","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00464-014-3720-6","volume":"29","author":"E Shlomovitz","year":"2015","unstructured":"Shlomovitz E, Pescarus R, Cassera MA, et al. Early human experience with per-oral endoscopic pyloromyotomy (POP. Surg Endosc. 2015;29:543\u201351.","journal-title":"Surg Endosc"},{"key":"113_CR39","doi-asserted-by":"crossref","unstructured":"Khashab MA, Ngamruengphong S, Carr-Locke D, Bapaye A, Benias PC, Serouya S, et al. Gastric peroral endoscopic myotomy for refractory gastroparesis: results from the first multicenter study on endoscopic pyloromyotomy (with video), Gastrointestinal Endoscopy (2016)","DOI":"10.1016\/j.gie.2016.06.048"},{"key":"113_CR40","unstructured":"Wellington J, Scott B, Kundu S, Stuart P, Koch KL. Effect of endoscopic pyloric therapies for patients with nausea and vomiting and functional obstructive gastroparesis. Auton Neurosci. 2016.\u00a0Jul 16. pii: S1566-0702(16)30102-3."}],"container-title":["Current Treatment Options in Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-016-0113-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11938-016-0113-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-016-0113-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T11:12:15Z","timestamp":1568459535000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11938-016-0113-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,8]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["113"],"URL":"https:\/\/doi.org\/10.1007\/s11938-016-0113-z","relation":{},"ISSN":["1092-8472","1534-309X"],"issn-type":[{"value":"1092-8472","type":"print"},{"value":"1534-309X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,8]]}}}